Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ClAraC vs FLAMSA Conditioning for High-Risk AML/MDS Stem Cell Transplant
NCT01423175Phase 2Unknown
- Sponsor
- Hannover Medical School
- Start
- Jul 2011
- Primary completion
- Jan 2015
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), sponsored by Hannover Medical School. Status: unknown.
02
Drugs
clofarabine
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT01423175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01423175.